Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Pyrexia, SARS-CoV-2 test
Clinical narrative: she had her first vaccine dose and afterwards she tested positive for covid; cough; headache; fever; temporarily lost her sense of taste and smell; temporarily lost her sense of taste and smell; congestion; This is a spontaneous report from a contactable other hcp. A 27-years-old female nurse (patient) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6206; Expiry Date: unknown), dose 1 via an unspecified route of administration, administered in Arm Left on 11Mar2021 at 14:30 (age at vaccination: 27 years) as dose 1, single for Prevention. The patient medical history was not reported. The patient Concomitant medications were not reported. The patient has not received other vaccines on same date with the Pfizer vaccine. The patient received no vaccine within 4 weeks of the current vaccination. No adverse events was reported following prior vaccinations. The patient was a non-smoker. The patient was not taking any medications routinely prior to the event being reported. On 15Mar2021, the patient experienced she had her first vaccine dose and afterwards she tested positive for covid. On 14Mar2021 the patient experienced cough, headache, fever, temporarily lost her sense of taste and smell, congestion. Vaccine was not Administered at Military Facility. The adverse event did not cause visit to emergency room or physician office. The patient was not hospitalized. There were predisposing factors. culture was not performed. It was unknown if the patient had SARS-CoV2 antibodies at diagnosis. The patient was not admitted to an Intensive Care Unit. The patient did not display clinical signs at rest indicative of severe systemic illness. The patient did not require supplemental oxygen (including high flow or ECMO) or receive mechanical ventilation. The event did not require the initiation of new medication or other treatment or procedure. It was unknown how many days from the SARS-CoV2 diagnosis did it take before the SARS-CoV2 antigen test became negative. It was not applicable if preexisting diseases worsened during the SARS-CoV2 infection. The patient has not been treated with immunomodulating or immunosuppressing medications or received any other vaccines around the time of COVID-19 vaccination. There was a Product Complaint. It was reported that the patient had her first vaccine dose and afterwards she tested positive for covid. She was tested for the Covid 19 virus with the PCR test on Monday 15Mar2021, the results came back positive on Wednesday 17Mar2021. She does the Covid 19 PCR testing as part of her job. She gets tested for Covid 19 twice weekly herself. Before getting the positive Covid 19 results she stated she has been tested for the Covid 19 virus about 40 times with the Covid PCR test. She had a cough, headache, fever, and temporarily lost her sense of taste and smell. She believes losing her taste and smell is more related to her congestion. Her symptoms began on Sunday, 14Mar2021. She reports her symptoms have improved greatly. She barely has a cough anymore. Her taste and smell have come back. She has a slight cough, a dry cough but that should be gone by the weekend. She would say she has recovered. Having the Covid 19 virus never felt unmanageable to her. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 15Mar2021. The patient did not receive any additional therapies for COVID-19. Outcome of the events were recovered on an unspecified date in 2021.   The Source of assessment was reported as Primary Source Reporter and Method of assessment as Global Introspection and drug result was reported as unrelated.  Follow-up (24Mar2021): This is a follow-up spontaneous report from a Pfizer sponsored Program CO-VAX US Support. It was reported that the second dose was scheduled on 01Apr2021.   Follow-up (26Mar2021): This is a follow-up spontaneous report from a Pfizer sponsored Program CO-VAX US Support. No new information was updated.   Follow-up (02Apr2021): This follow-up contains no new medically significant information.  No follow up attempts are possible. No further information is expected.